Ciplamed App (iOS) – Click here
Website link: www.ciplamed.com
While the nation encounters a steady rise in breathing related problems, people are seeking credible & vital information on their disease conditions & its management.
The new Breathefree website will continue to be a complete and comprehensive source of patient information tool relating to breathing disorders and is also designed to be a powerful, closely connected community of people suffering from various breathing ailments. So, while anyone can, of course, learn everything about a breathing issue that may be bothering them, it also provides a powerful platform for people to share experiences, insights and stories of personal triumphs.
Breathefree Website link – Click here
Nikhil Chopra, Head India Business, Cipla, "Continuing Cipla's commitment towards patient centricity & Innovation; we are happy to bring to life 2 great educational efforts delivered through a digital route. We hope these assets will empower better healthcare decisions & outcomes."
Kiran Pai, Head Digital Marketing, Cipla, "Simplified content & great user interface is the hallmark of new age digital education platforms & we have tried to do just that with Ciplamed & breathe free platforms. Needless to mention that both platforms are mobile responsive to fuel consumption across the mobile first segment."
Dr Jaideep Gogaty, Chief Medical Officer, Cipla "Cipla has always partnered with the medical fraternity towards enhancing patient care. Ciplamed and Breathefree are two unique initiatives in this continuing endeavour. While Ciplamed provides a wide range of comprehensive and practice-oriented medical resources and updates for the busy healthcare professional, Breathefree aims to enhance patient awareness on asthma, COPD and allergic rhinitis in a lucid and user-friendly format."
About Cipla Ltd.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. In the last 80+ years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 80 countries. Our portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla's emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla's research and development focuses on developing innovative products and drug delivery systems.
Cipla Website link: www.cipla.com